Executive Summary
Uranium Energy Corp (0LJQ.L) reported a challenging QQ4 2024 quarter with a negative bottom line driven by operating costs and working capital dynamics, while revenues for the quarter were not disclosed in the provided dataset. The reported EBITDA was negative at approximately -$15.75 million and net income stood at -$15.12 million, translating to an EPS of -$0.038. Notably, the company maintains a solid liquidity position with total cash and equivalents around $87.5 million at quarter-end and an overall net cash position (net debt negative) of roughly -$84.9 million, supported by a modest balance sheet leverage footprint (total debt around $2.6 million). Financing activity provided $13.78 million via common stock issuance, contributing to a stable cash balance despite negative operating cash flow (approx. -$12.62 million) and modest capex outlay (~$0.87 million) during the quarter.
The core issue for QQ4 2024 appears to be profitability and cash flow normalization rather than a near-term liquidity constraint. Gross profit was negative by about $0.563 million on costs of revenue of $6.237 million, and operating expenses totaled $8.122 million, driving a quarterly operating loss of $19.057 million. Although YoY gross profit showed a sizable improvement (reported YoY gross profit change of about +90%), the quarter still reflects a loss position driven by cost structure and working capital changes rather than a lack of asset base. The balance sheet remains robust, with total assets of ~$889.8 million and a strong current liquidity profile (current ratio ~8.05, quick ratio ~5.46, cash ratio ~3.00).
Looking ahead, the absence of formal long-range guidance in the QQ4 2024 data limits explicit forward targets. The investment thesis hinges on uranium price recovery, successful progression of Texas ISR assets in the portfolio, and favorable capital allocation that translates this asset base into recurring cash flow. In the near term, investors should monitor (i) uranium price and demand dynamics, (ii) progress and ramp-up potential of active projects, and (iii) any further equity financings or asset monetization that could bolster liquidity and reduce cost of capital.
Key Performance Indicators
QoQ: -37.68% | YoY:-67.39%
QoQ: 23.18% | YoY:-555.13%
QoQ: 21.97% | YoY:-536.78%
Key Insights
Revenue: Not disclosed for QQ4 2024 in the provided data; previous quarters show limited disclosed revenue figures (e.g., Q3 2024 and earlier). Gross Profit: -$0.563 million; YoY change +90.07%, QoQ change -2.18%. Operating Income: -$19.057 million; YoY change -67.39%, QoQ change -37.68%. Net Income: -$15.115 million; YoY change -555.13%, QoQ change +23.18%. EPS: -$0.038; YoY change -536.78%, QoQ change +21.97%. EBITDA: -$15.746 million. Free Cash Flow (FCF): -$13.487 million; FCF per share: -$0...
Financial Highlights
Revenue: Not disclosed for QQ4 2024 in the provided data; previous quarters show limited disclosed revenue figures (e.g., Q3 2024 and earlier). Gross Profit: -$0.563 million; YoY change +90.07%, QoQ change -2.18%. Operating Income: -$19.057 million; YoY change -67.39%, QoQ change -37.68%. Net Income: -$15.115 million; YoY change -555.13%, QoQ change +23.18%. EPS: -$0.038; YoY change -536.78%, QoQ change +21.97%. EBITDA: -$15.746 million. Free Cash Flow (FCF): -$13.487 million; FCF per share: -$0.0329. Cash at end of period: $94.784 million. Net cash from operating activities: -$12.616 million; Net cash used in investing activities: -$1.359 million; Net cash provided by financing activities: +$13.784 million. Balance sheet highlights: Total assets $889.828 million; Total current assets $235.244 million; Total current liabilities $29.222 million; Total non-current liabilities $82.493 million; Total stockholders’ equity $778.113 million. Liquidity ratios: Current ratio 8.05; Quick ratio 5.46; Cash ratio 3.00. Net debt: -$84.933 million (net cash position). Inventory on hand: $75.833 million; PPE net: $578.048 million. Weighted average shares (basic) 397.31 million; EPS diluted -$0.038.
Income Statement
| Metric |
Value |
YoY Change |
QoQ Change |
| Gross Profit |
-563.00K |
90.07% |
-2.18% |
| Operating Income |
-19.06M |
-67.39% |
-37.68% |
| Net Income |
-15.12M |
-555.13% |
23.18% |
| EPS |
-0.04 |
-536.78% |
21.97% |
Key Financial Ratios
operatingCashFlowPerShare
$-0.03
freeCashFlowPerShare
$-0.03
priceEarningsRatio
-39.84
Management Commentary
Transcript data not provided in the dataset. No management quotes or call highlights are available from the QQ4 2024 materials to extract insights or thematic quotes.
Forward Guidance
No explicit guidance was provided in the QQ4 2024 data. Given the absence of posted forward targets, the forward outlook must be inferred from industry dynamics and the company’s balance sheet and cash flow position. Investment considerations include: (a) potential uplift in uranium prices could improve realized margins and potentially unlock revenue recognition from existing ISR projects; (b) continued emphasis on balance sheet strength may fund project development without fresh dilution, given the net cash position; (c) potential risks include sustained negative quarterly earnings, working capital volatility, timing of project milestones, and any future equity raises. Monitoring suggests focusing on uranium market trajectory, project development milestones (e.g., Texas ISR assets), inflationary/capital costs, and any management commentary on capital allocation strategy and milestone-based cash flow realization.